Skip to main content

Peer Review reports

From: Usefulness of monitoring circulating tumor cells as a therapeutic biomarker in melanoma with BRAF mutation

Original Submission
26 Sep 2020 Submitted Original manuscript
26 Oct 2020 Reviewed Reviewer Report
16 Nov 2020 Reviewed Reviewer Report
29 Nov 2020 Author responded Author comments - Yukiko Kiniwa
Resubmission - Version 2
29 Nov 2020 Submitted Manuscript version 2
19 Dec 2020 Reviewed Reviewer Report
3 Jan 2021 Reviewed Reviewer Report
13 Jan 2021 Author responded Author comments - Yukiko Kiniwa
Resubmission - Version 3
13 Jan 2021 Submitted Manuscript version 3
6 Mar 2021 Author responded Author comments - Yukiko Kiniwa
Resubmission - Version 4
6 Mar 2021 Submitted Manuscript version 4
Publishing
8 Mar 2021 Editorially accepted
17 Mar 2021 Article published 10.1186/s12885-021-08016-y

You can find further information about peer review here.

Back to article page